Dopamine receptor (non-ergoline agonist)
Assets acting on this target.
- Class
- Non-ergoline dopamine agonist
By indication
Related mechanisms
Dopamine receptor (non-ergoline agonist) drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Apomorphine (Apokyn)Apokyn | Britannia Pharmaceuticals Ltd., Supernus Pharmaceuticals | small molecule | Approved | Approved in Parkinson's Disease |
| Apomorphine (Onapgo)Onapgo | Britannia Pharmaceuticals Ltd., Supernus Pharmaceuticals | small molecule | Approved | Approved in Parkinson's Disease |
| SER-252 (PEOZ-apomorphine) | Serina Therapeutics | small molecule | Phase 1 | Phase 1 in Parkinson's Disease |